Shares of PureTech Health PLC Sponsored ADR (NASDAQ:PRTC - Get Free Report) rose 0.6% during mid-day trading on Monday . The company traded as high as $17.50 and last traded at $17.25. Approximately 1,697 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 5,016 shares. The stock had previously closed at $17.15.
PureTech Health Price Performance
The firm has a fifty day moving average of $17.82 and a 200 day moving average of $18.03.
Institutional Trading of PureTech Health
An institutional investor recently raised its position in PureTech Health stock. Pentwater Capital Management LP increased its position in shares of PureTech Health PLC Sponsored ADR (NASDAQ:PRTC - Free Report) by 39.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 33,560 shares of the company's stock after purchasing an additional 9,449 shares during the period. Pentwater Capital Management LP owned 0.14% of PureTech Health worth $664,000 at the end of the most recent quarter. 0.04% of the stock is currently owned by institutional investors.
PureTech Health Company Profile
(
Get Free Report)
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
See Also
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
